IROS 2024 Satellite Symposium

INARI Symposium: Is pro-active PE Management finally a reality? How updated guidelines, risk stratification based on stronger predictors, lytic-free technologies and robust clinical data changes outcomes of critically sick patients.

 

     
 
   

 

IROS 2024. 11–13 January. Salzburg, Austria

 

 Inari Medical logo
 
     
 

 

Satellite Symposium:

 

Is pro-active PE Management finally a reality?
How updated guidelines, risk stratification based on stronger predictors, lytic-free technologies and robust clinical data changes outcomes of critically sick patients.

 

  

 

Thursday 11th January | 16:00 - 16:50 | Room: Mozart 1

 
     
 

 

   
Prof Bernhard Gebauer

Prof Bernhard Gebauer

University Hospital Charité, Berlin, Germany

 

The existing and planned evidence for catheter-assisted thrombectomy with large-lumen catheters.

 

  
Dr Luca De Paoli

Dr Luca De Paoli

Klinikum Klagenfurt am Wörthersee, Austria

 

Large-lumen catheter thrombectomy in clinical practice: case studies and patient pathway.

 

  
Dr Michael Kostrzewa

Dr Michael Kostrzewa

Kantonsspital Baden, Switzerland

 

Shock prevention and emergency revascularisation: Patient selection and pathway based on current guidelines and consensus papers from ESC and DGK.

 

  
 
     
 

 

Join us at Booth #38 for Hands-On Device Session

 

  
     
 

 

Removing large clots from large vessels.
Lytic-free approach.

 

  
     
 

 

www.inarimedical.com

 

  
     
 

 

ClotTriever® Intended Purpose

 

The ClotTriever® Thrombectomy System is intended for use in the lower peripheral vasculature to remove thrombi and emboli, and for the treatment of Deep Vein Thrombosis (DVT) in persons 18 years or older.

 

See Instructions for Use for complete indications for use, contraindications, warnings, and precautions.

 

FlowTriever® Intended Purpose

 

The FlowTriever® Retrieval/Aspiration System's intended purpose is for use in the peripheral vasculature and pulmonary arteries for the treatment of intermediate- and high-risk pulmonary embolism in patients 18 years or older deemed medically suitable for mechanical thrombectomy.

 

See Instructions for Use for complete indications for use, contraindications, warnings, and precautions.

 

Caution: Federal (USA) law restricts these devices to sale by or on the order of a physician.
All trademarks are property of their respective owners.

 

Inari Medical, Inc. headquarters: 6001 Oak Canyon, Suite 100  |  Irvine CA 92618
Inari Medical Europe GmbH, a subsidiary of Inari Medical, Inc.  |  Messeplatz 10  |  4058 Basel, Switzerland